Stockscreener 앱 받기
0.3117
3.50%
-0.0113
시간 외 거래:
.32
0.0083
+2.66%
Virpax Pharmaceuticals Inc 주식(VRPX)의 최신 뉴스
Virpax Pharmaceuticals Raises $6M and Signs Investor Agreements - TipRanks
Spartan Capital Securities Serves as Sole Placement Agent in Virpax Pharmaceuticals' $6 Million Follow-On Offering - The Manila Times
Virpax Pharmaceuticals Closes of $6.0 Million Public Offering of Common Stock - citybiz
Virpax Secures Critical $6M Funding: What This Means for Probudur's Future - StockTitan
Virpax Pharmaceuticals Prices of $6 Million Public Offering of Common Stock - citybiz
Virpax Pharmaceuticals sets public offering at $0.20 per share - Investing.com India
Virpax Secures Critical $6M Funding: Game-Changing Move for Probudur Development - StockTitan
Virpax Pharmaceuticals stock hits 52-week low at $0.29 - MSN
What's Going With Penny Stock Virpax Pharmaceuticals On Monday? - MSN
Virpax Pharmaceuticals enacts reverse stock split - Investing.com
Virpax Pharmaceuticals enacts reverse stock split By Investing.com - Investing.com South Africa
Virpax Pharmaceuticals granted Nasdaq listing extension - Investing.com
Virpax Pharmaceuticals Regains Nasdaq Compliance - MSN
Amendments to Independent Contractor Agreements at Virpax Pharmaceuticals Clarify Roles and Responsibilities - Defense World
Virpax Updates Executive Agreements for Legal Compliance - TipRanks
Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) Short Interest Update - Defense World
Virpax Pharmaceuticals, Inc. Appoints Jaydriane Panis to the Board - Marketscreener.com
Virpax Pharmaceuticals names new board director - Investing.com
Virpax Pharmaceuticals names new board director By Investing.com - Investing.com UK
Pre-market Movers: EWTX, TNXP, LNSR, VRDN... - RTTNews
Virpax Pharmaceuticals announces board member resignation By Investing.com - Investing.com South Africa
Virpax Pharmaceuticals announces board member resignation - Investing.com
Virpax Pharmaceuticals Announces Board Member Resignation - TipRanks
Virpax Pharmaceuticals stock hits 52-week low at $0.36 By Investing.com - Investing.com Canada
Virpax Pharmaceuticals stock hits 52-week low at $0.36 - Investing.com
Virpax Pharmaceuticals Extends Collaboration with NIH Center for Pain Management Innovation - MSN
VRPX (Virpax Pharmaceuticals) Enterprise Value : $3.71 Mil (As of Dec. 01, 2024) - GuruFocus.com
Virpax Pharmaceuticals lowers quorum requirement By Investing.com - Investing.com South Africa
Virpax Pharmaceuticals lowers quorum requirement - Investing.com India
Virpax Pharmaceuticals : Amendments to Bylaws Form 8 K - Marketscreener.com
Virpax Pharmaceuticals Announces Positive Results in Study for Long-Lasting Pain Relief Formulation - MSN
Virpax Pharmaceuticals regains Nasdaq compliance By Investing.com - Investing.com Nigeria
Virpax Pharmaceuticals regains Nasdaq compliance - Investing.com India
Virpax Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Virpax Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements and Makes Key Appointments - Defense World
Virpax Pharmaceuticals Strengthens Leadership and Expands Collaborations - TipRanks
Maxim Group Downgrades Virpax Pharmaceuticals (VRPX) - MSN
Virpax Announces Positive Results for the Swine Model Dose Range Finding Study for Probudur - Marketscreener.com
Why Is Virpax Pharmaceuticals Stock Gaining On Friday? - Benzinga
Virpax Pharmaceuticals extends NIH pain management research By Investing.com - Investing.com Australia
Virpax Pharma Gets Government Cooperation Deal Extension - Marketscreener.com
Virpax Pharmaceuticals extends NIH pain management research - Investing.com India
5.49%
0.79%
자본화:
|
볼륨(24시간):